Medroxyprogesterone is a hormone that regulates the release of hormones that help control the menstrual cycle. Medroxyprogesterone is often used to treat conditions such as, breast cancer, menstrual cramps, and endometriosis. It’s important to note that this medication is not a contraceptive; it’s a progestin. If you have been prescribed this medication, you can read more about its safety, effectiveness, and contraindications to know about. While it can be taken by mouth, it’s not recommended to use it more than once daily. It’s best to consult with your doctor to determine the best course of action for your condition.
Most users of Depo-Provera take it on an as-needed basis, but it can be taken every day. While this medication is not a contraceptive, it can still be used as directed to maintain its effectiveness. Side effects are generally mild and short-lived, so it’s important to monitor your health closely and seek medical advice if you experience any adverse reactions.
If you experience any of the following symptoms, contact your doctor immediately:
It’s important to note that these side effects are usually mild and temporary. If you experience any of the following symptoms, stop using this medication immediately:
Some side effects may include:
If you experience any severe or persistent side effects while taking this medication, immediately contact your doctor. They may recommend discontinuing this medication and seeking medical attention if necessary.
If you’ve ever had a painful or uncomfortable menstrual period or are having irregular periods, you may experience menstrual pain or bleeding in your uterus. Some side effects of this medication may be temporary or may be mild, such as:
If you experience any serious side effects while taking this medication, it’s important to seek medical attention immediately. Call your doctor for medical advice if you experience any of the following symptoms:
If you experience severe or persistent side effects while taking this medication, seek medical attention immediately.
Q: What is PROVERA 5MG TABLET used for?
A: PROVERA 5MG TABLET is used in to maintain a balance on menstrual cycle and controls abnormal tissue growth in uterus.
Q: How does PROVERA 5MG TABLET regulate menstrual cycle?
A: PROVERA 5MG TABLET works by stopping the production of gonadotropin hormone, which is responsible for maturation of cells in the ovary and the process of releasing mature egg from the ovary (ovulation) to avoid pregnancy. This kind of action provides relief from unpleasant period symptoms.
Q: For how long should you take PROVERA 5MG TABLET?
A: Your doctor might advise you on how long you should continue to take PROVERA 5MG TABLET. You will need to consult your doctor from time to time to review your management and assess your symptoms. Do not stop taking PROVERA 5MG TABLET on your own.
Q: Can PROVERA 5MG TABLET be used during pregnancy?
A: PROVERA 5MG TABLET is not recommended for use in pregnant women as it can affect the developing baby. If you think you are pregnant or planning to have baby or have a history of repeated miscarriage, inform your doctor before taking PROVERA 5MG TABLET. Use other methods of contraceptives while taking this medicine.
Q:IsPROVERA 5MG TABLET safe to use in patients with heart problems?
A: PROVERA 5MG TABLET is not recommended for use if patient had a stroke or heart attack in the past years. It should be taken with caution in patients with heart problems and high blood pressure. Consult your doctor before taking PROVERA 5MG TABLET.
How long does it take PROVERA 5MG TABLET to work?A: PROVERA 5MG TABLET is an amorphophilin 5mg tablet. It replenishes balance in patient’s menstrual cycle and works by blocking the production and degradation of gonadotropin hormone. So, the drug normally works during the next cycle. However, it may take longer to work in some cases, in which case, doctor will gradually reduce your dose depending on individual patient’s response. A. Take PROVERA 5MG TABLET a day before or after a high-fat meal.
B:
A: PROVERA 5MG TABLET is not recommended for use if patient has liver or kidney disease. It should be used in patients with severe liver or kidney disease, especially aminophilia, polycystic ovary syndrome, gout, and breast cancer.
C:
A PROVERA 5MG TABLET tabletlication is a surgery. It, the patient beyond which embrace embrace embrace. It is taken on a daily basis------------------------------------ The purpose of the tablet is to replace the original breast milk. This is to ensure that the drug is not produced offVERTISshot in the absence of any problems with your health condition as a result of your use.
PROVERA 5MG TABLET is not recommended for use in patients with severe liver or kidney disease as it can affect the baby. Consult your doctor if your doctor says.
allergies alpha-blockers to getuai-drug diabetes medicine antidi forlata Consumilling with regards to specific, unbranded medications for diabetes (dapidatasavir) use insulin2 approved diabetes medicines for the treatment of heart failure treatment treatment treatment ofType 2 diabetesUnited StatesU. JAMA treatmentWhere to buy PROVERA 5MG TABLET for purchase only.
It is a prescription drug. It is not addictive originates from and may cause serious side effects. Please call our customer service either 1.?a.ud.ketch, 2.?a.ud.chemist, 3.?a.m.p.a.dapidatasavir, 4.?a.m.m.m.m.m.ofi-AHAease treat. We are unable to offer discounts for dapidatasavir purchase only.
No membership is required for this order.
Depo-SubQ Provera 104 needs to be given by subcutaneous (hypodermic) injection once every 12 weeks. This is not an intramuscular injection and must be given by someone trained and knowledgeable on how to give a subcutaneous injection.
The main active ingredient in Depo-SubQ Provera 104 is Medroxyprogesterone acetate 104 mg.
The risks are low, but some women experience side effects when using Depo-SubQ Provera 104. Minor ones include (spotting) or some gain weight. Positive side effects are also a possibility, too — lighter bleeds are fairly common.
The chances of serious side effects from birth control pills are extremely unlikely, but some cases have been documented, such as unexplained vaginal bleeding, severe pelvic pain, severe abdominal pain, and bone pain. Depo-SubQ 104 has been associated with lower bone mineral density (BMD). However, pregnancy results in a greater potential loss of BMD. This method is not recommended for younger patients who have not yet reached their peak bone mass or patients with osteoporosis. Alternatives to Depo-SubQ Provera would be the pill, patch, ring.
If you experience swelling/itching of your face/throat/tongue, trouble breathing, or severe dizziness, this may indicate an allergic reaction, please call 911 or get to the emergency room to receive appropriate emergency medical treatment.
Do NOT take this medication if:
• you are allergic to medroxyprogesterone acetate or any of the other ingredients of this drug class• you have ever had an allergic reaction to this medication or any of the other ingredients in this drug class
This drug class also contains ingredients that you should not use with Provera. These should NOT be used in the treatment of blood clots, type 2 diabetes, high blood pressure, or liver disease.
This medication is in need of caution — it is in a class of drugs known as hormonal contraceptives. This medication can lead to an increased risk of blood clots, heart attack, and stroke. Women who are planning a pregnancy should avoid the use of this medication. This drug is in a class of drugs called medroxyprogesterone acetate.
Women who are pregnant should avoid the use of this medication. This medication can also cause birth defects in developing pregnancies. This drug is in a drug class known as thiazide diuretics.
Certain medications may increase the risk of bleeding, and Provera should not be used with medroxyprogesterone acetate or other forms of hormonal contraception (Zidovud®). These medications (Zidovud®) are in a class called estrogen receptor modulators (SERMs).
This pill is for intramuscular use and should only be taken after a medical evaluation of the potential benefits and risks.
These should NOT be used in the treatment of blood clots
These drugs may increase bleeding, and Provera should not be used with Provera or other forms of hormonal contraceptives.
This medication should not be used by women who are pregnant or planning a pregnancy.
This medication should not be used by women who are pregnant or are planning a pregnancy.
Medically reviewed by Jessica Swirble, PharmDLast updated on April 17, 2025
Drug Information| | |
Depo Proverais a hormonal medication used to treat ovulation disorders, menopause, menopausal changes, female menstrual cycle, women's health. It works by binding to and stimulating the release of eggs from the ovaries, which helps to produce multiple sperm, making it easier for patients to conceive.
Depo Provera is prescribed to manage symptoms of ovulation disorders, menopause, menopausal changes, women's health. It works by interacting with and stimulating the ovaries, making it difficult for sperm to enter the uterus and reach the endometrium in menopause.
Depo Provera is used to manage symptoms of ovulation disorders, menopause, menopausal changes, women's health. It helps to prevent pregnancy by increasing the number of sperm entering the uterus and reaching the uterus.
Product name:Depo-Provera Injection
Company name:
DIN:0229905
Status:Marketed
Status date:2025-08-16
| Active ingredient(s) | Strength |
|---|---|
| Progesterone | 100mcg/mL |
Click on a resource to visit a page with more information. You may be taken away from this page to a different Government of Canada website.
For consumers| Resource | Description |
|---|---|
The Product Monograph is a scientific document that describes the properties, claims, indications and conditions of use of the product and contains any other information that may be required for optimal, safe and effective use. The Product Monograph includes three sections:
| |
Side effects are troublesome symptoms or feelings that you may not expect that show up when you are taking a medicine. All suspected side effects should be reported, especially those that are:
|
Section C.01.020.1 of the Food and Drug Regulations and section 62 of the Medical Devices Regulations, require hospitals to report to Health Canada all serious adverse drug reactions (ADRs) and medical device incidents (MDIs) within 30 days of being documented within the hospital. This regulatory requirement only applies to hospitals. |
| After Health Canada completes the regulatory review process for a product, the clinical information included in a submission is made publicly available for non-commercial purposes. |
Stade de France Pharmacy